Oligomerization Partially Explains the Lowering of Aβ42 in Alzheimer’s Disease Cerebrospinal Fluid

By  

Neurodegenerative Diseases, Vol. 6, Iss. 4, 2009-06 ,pp. : 139-147

Karger

Access to resources Recommend Favorite

Relative Ratio and Level of Amyloid-β 42 Surrogate in Cerebrospinal Fluid of Familial Alzheimer Disease Patients with Presenilin 1 Mutations

By  

Neurodegenerative Diseases, Vol. 13, Iss. 2-3, 2013-10 ,pp. : 166-170

Karger

Access to resources Recommend Favorite

Identification of Novel APP/Aβ Isoforms in Human Cerebrospinal Fluid

By  

Neurodegenerative Diseases, Vol. 6, Iss. 3, 2009-02 ,pp. : 87-94

Karger

Access to resources Recommend Favorite

Analysis of APL1β28, a Surrogate Marker for Alzheimer Aβ42, Indicates Altered Precision of γ-Cleavage in the Brains of Alzheimer Disease Patients

By  

Neurodegenerative Diseases, Vol. 7, Iss. 1-3, 2010-02 ,pp. : 42-45

Karger

Access to resources Recommend Favorite

Aβ Immunotherapy: Lessons Learned for Potential Treatment of Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 2, Iss. 5, 2006-02 ,pp. : 255-260

Karger

Access to resources Recommend Favorite